RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Clinical efficacy and safety of Razumab(R) (CESAR) study: Our experience with the world's first biosimilar Ranibizumab.

Clinical efficacy and safety of Razumab(R) (CESAR) study: Our experience with the world's first biosimilar Ranibizumab.

Add to Collection
2021 Feb Others Fist_Author_Year_PM

Full Author : ['Verma, Lalit', 'Thulasidas, Mithun', 'Purohit, Ajay', 'Gupta, Avnindra', 'Narula, Ritesh', 'Talwar, Dinesh']
Journal Title : Indian journal of ophthalmology
Chapter : Section3
Journal Year : 2021
Cited by : Not Available

PURPOSE: : The aim of this study was to evaluate the efficacy and safety of Razumab (the biosimilar Ranibizumab by Intas Pharmaceuticals Ltd.) for the treatment of chorioretinal vascular diseases such as diabetic macular edema (DME), choroidal neovascular.....

Keywords : ["world first biosimilar ranibizumab", "razumabr cesar study", "clinical efficacy", "safety", "experience"]